Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | MORPHINE SULFATE |
| Generic name | MORPHINE SULFATE |
| Active ingredient(s) | MORPHINE SULFATE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512 |
| NDC | 63304-452-01 |
| Full product label | Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide within in the USA. |
| Quantity | 9840 bottles |
| Recall initiated | 2025-02-06 |
| Report date | 2025-03-12 |
| Recall completed | — |
| Recall number | D-0249-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗